EICHORCondition: Progressive Supranuclear Palsy · Sponsor: Transposon Therapeutics, Inc.
This is a Phase 2a study to assess the safety and tolerability of TPN-101 patients with PSP.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| St. Joseph's Hospital and Medical Center, Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| UC San Diego Altman Clinical And Translational Research Institute | La Jolla, California, United States | — |
| UCSF Neurosciences Clinical Research Unit (NCRU) | San Francisco, California, United States | — |
| Rocky Mountain Movement Disorders Center | Englewood, Colorado, United States | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton, Florida, United States | — |
| UFHealth Fixel Institute for Neurological Diseases | Gainesville, Florida, United States | — |
| Johns Hopkins University School of Medicine | Baltimore, Maryland, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Quest Research Institute | Farmington Hills, Michigan, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
| Cleveland Clinic Lou Ruvo Center for Brain Health | Las Vegas, Nevada, United States | — |
| Irving Center for Clinical and Translational Research | New York, New York, United States | — |
+ 2 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04993768